ALIGOS THERAPEUTICS, INC.

Profile

Company Names

ALIGOS THERAPEUTICS, INC.

Addresses

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(800) 466-6059

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$282,153,207.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-02-11 
$105,003,206.00 
$105,003,206.00 
$0.00 
Equity 
2
2023-10-25 
$92,150,000.00 
$92,150,000.00 
$0.00 
Equity 
1
2019-12-23 
$85,000,001.00 
$125,000,167.00 
$40,000,166.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HARDEAN 
 
ACHNECK 
EXECUTIVE OFFICER
ALIGOS THERAPEUTICS, INC.
LEONID 
 
BEIGELMAN 
EXECUTIVE OFFICER, DIRECTOR
ALIOS BIOPHARMA INC   |  ALIGOS THERAPEUTICS, INC.
LAWRENCE 
 
BLATT 
EXECUTIVE OFFICER, DIRECTOR
ALIOS BIOPHARMA INC   |  ALVEO TECHNOLOGIES INC.   |  ALIGOS THERAPEUTICS, INC.
LAWRENCE 
M. 
BLATT 
EXECUTIVE OFFICER, DIRECTOR
ALIGOS THERAPEUTICS, INC.
LESLEY 
ANN 
CALHOUN 
EXECUTIVE OFFICER
TANGO THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.
SUSHMITA 
 
CHANDA 
EXECUTIVE OFFICER
ALIGOS THERAPEUTICS, INC.
MARGARITA 
 
CHAVEZ 
DIRECTOR
CARMA THERAPEUTICS INC.   |  CARISMA THERAPEUTICS INC.   |  MAGNOLIA NEUROSCIENCES CORP   |  RODEO THERAPEUTICS CORP   |  NITROME BIOSCIENCES, INC   |  AMBAGON THERAPEUTICS INC.   |  SNC THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.
BRIAN 
 
DOWD 
EXECUTIVE OFFICER
ALIGOS THERAPEUTICS, INC.
JOHN 
 
FRY 
EXECUTIVE OFFICER
AMEE INC   |  FS ONEEQUITY PARTNERS CO. L.P.   |  VTV THERAPEUTICS INC.   |  ALIGOS THERAPEUTICS, INC.
KATHLEEN 
 
GLAUB 
DIRECTOR
CODEXIS, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC
K. 
PETER 
HIRTH 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  ALIGOS THERAPEUTICS, INC.
PETER 
 
HIRTH 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  ALIOS BIOPHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  ICONIC THERAPEUTICS INC   |  SUTROVAX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC   |  TREX HOLDINGS INC.
BRIDGET 
 
MARTELL 
DIRECTOR
ACHIEVE LIFE SCIENCES, INC.   |  AYALA PHARMACEUTICALS, INC.   |  ALIGOS THERAPEUTICS, INC.
MATTHEW 
 
MCCLURE 
EXECUTIVE OFFICER
ALIGOS THERAPEUTICS, INC.
PETER 
 
MOLDT 
DIRECTOR
CARDEAS PHARMA CORP   |  ALLAKOS INC.   |  BIOCLIN THERAPEUTICS, INC.   |  CORVUS PHARMACEUTICALS, INC.   |  VASCULOX, INC.   |  E-SCAPE BIO, INC.   |  TIOMA THERAPEUTICS, INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  OUTPOST MEDICINE, LLC   |  SWIFT HEALTH SYSTEMS INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCAPE BIO, INC.   |  AVALYN PHARMA INC.
CAROLE 
 
NEUCHTERLEIN 
DIRECTOR
LYSOSOMAL THERAPEUTICS, INC.   |  MILLENDO THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.
JACK 
 
NIELSEN 
DIRECTOR
PROTEIN FOREST, INC.   |  ALIOS BIOPHARMA INC   |  NEOMEND INC   |  APOLLO ENDOSURGERY INC   |  BIOCLIN THERAPEUTICS, INC.   |  UNCHAINED LABS   |  KANYOS BIO, INC.   |  PROCEPT BIOROBOTICS CORP   |  APOLLO ENDOSURGERY US INC   |  HARMONY BIOSCIENCES II, INC.   |  MACULOGIX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  INSTIL BIO, INC.   |  OCELOT BIO, INC.   |  VIVO INNOVATION FUND II, L.P.   |  INSPIRNA, INC.   |  MANAT BIO, INC.
CAROLE 
 
NUECHTERLEIN 
DIRECTOR
LYSOSOMAL THERAPEUTICS, INC.   |  CIVI BIOPHARMA HOLDINGS, INC.   |  MACULOGIX, INC.   |  ENTRADA THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.
HEATHER 
 
PRESTON 
DIRECTOR
VIROBAY INC   |  OTONOMY, INC.   |  VIBRYNT, INC   |  UNCHAINED LABS   |  GENOA PHARMACEUTICALS, INC.   |  ALDER BIOPHARMACEUTICALS INC   |  AKOUOS, INC.   |  AVALYN PHARMA INC.   |  ENTASIS THERAPEUTICS HOLDINGS INC.   |  ALIGOS THERAPEUTICS, INC.
LUCINDA 
 
QUAN 
EXECUTIVE OFFICER
ALIGOS THERAPEUTICS, INC.
JAMES 
 
SCOPA 
DIRECTOR
TV2 HOLDING CO   |  ASTUTE MEDICAL, INC.   |  CONATUS PHARMACEUTICALS INC   |  TRIVASCULAR TECHNOLOGIES, INC.   |  IDUN PHARMACEUTICALS INC   |  BLADE THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
JULIAN 
 
SYMONS 
EXECUTIVE OFFICER
ALIGOS THERAPEUTICS, INC.
TOM 
 
WOIWODE 
DIRECTOR
VERSANT VENTURE CAPITAL V, L.P.   |  VERSANT AFFILIATES FUND V, L.P.   |  VERSANT OPHTHALMIC AFFILIATES I, L.P.   |  VERSANT VENTURE CAPITAL V (CANADA), LP   |  ALIGOS THERAPEUTICS, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
MICHAEL 
 
YI 
DIRECTOR
GOSSAMER BIO, INC.   |  NEXTCURE, INC.   |  OMNIOME, INC.   |  BEAM THERAPEUTICS INC.   |  ALIGOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-28
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-02-11 
2023-11-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2020-01-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES LLC
NONE
NONE
NONE
PIPER SANDLER + CO.
NONE
PIPER SANDLER + CO.
NONE
PIPER SANDLER + CO.
665